High Risk of Acquired Immune Deficiency Syndrome (AIDS) and of AIDS Related Complex (ARC) in Hemophiliacs Seropositive for more than 5 Years

Summary

A group of 90 hemophiliacs who had been regularly treated with non virus-inactivated factor VIII or IX concentrates were studied in 1983. At that time 50 patients were HIV-1-antibody positive, 6 additional seroconversions occurred until 1985. 26 of the 50 patients seropositive in 1983 are currently asymptomatic. 4 patients have developed the lymphadenopathy syndroffie, 9 patients AIDS and 11 patients ARC (CDC IV C 2). 6/9 cases of AIDS and 10/11 cases of ARC have occurred only after 1985. Patients, who subsequently became symptomatic, had significantly higher IgG levels in 1983, otherwise no predictive laboratory tests were identified. Patients with T4 counts above 500/μl became symptomatic later, but after 5 years the indicence of AIDS was comparable in patients with original T4 counts of more than or below 500/μl.

Keywords

Hemophilia - Clotting factor concentrates - Acquired immune deficiency syndrome - Human immune deficiency virus

• References

• 1 Hilgartner MW. AIDS and hemophilia. N Engl J Med 1987; 317: 1153-1154
• 2 Goedert JJ, Biggar RJ, Weiss SH, Eyster EM, Melbye M, Wilson S, Ginzburg HM, Grossman RJ, DiGioia RA, Sanchez WC, Giron JA, Ebbesen P, Gallo RC, Blattner WA. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science 1986; 231: 992-995
• 3 Ragni MV, Winkelstein A, Kingsley L, Spero JA, Lewis JH. 1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV-infection in patients with hemophilia A and B. Blood 1987; 70: 786-790
• 4 Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Korninger C, Neumann E, Liszka K, Knapp W, Mayr WR, Stingl G, Zeitlhuber U. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Thromb Haemostas 1983; 50: 552-556
• 5 Ledbetter JA, Evans RL, Lipinske M, Cunningham-Rundles C, Good RA, Herzenberg LA. Evolutionary conservation of surface molecules that distinguish T-lymphocytes helper/inducer and T-cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 1981; 153: 310-318
• 6 Allain JP, Laurian Y, Paul DA, Verroust F, Leuther M, Gazengel C, Senn D, Larrieu MJ, Bosser C. Long-term evaluation of HIV-antigen and antibodies to p 24 and gp 41 in patients with hemophilia: potential clinical importance. N Engl J Med 1987; 317: 1114-1120
• 7 Landbeck G. 18. Hämophiliesymposium. Hamburg: 6-7 11 1987
• 8 Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987; 107: 1-6
• 9 Hargraves MA, Jason JM, Chorba TL, Holman RC, Dixon GR, Eastham CJ, Brownstein AP, Heine P, Agle DP, Evatt BL. The Hemophilia/AIDS Collaborative Study Group. Hemophilic patient’s knowledge and educational needs concerning acquired immunodeficiency syndrome. Am J Hematol 1987; 26: 115-124
• 10 The Pennsylvania AIDS surveillance study group. Geographic differences in hemophilia-associated AIDS incidence in Pennsylvania. Blood 1987; 70: 1208-1210
• 11 Medley GF, Anderson RM, Cox DR, Billard L. Incubation period of AIDS in patients infected via blood transfusion. Nature 1987; 328: 719-721
• 12 Holzman RS, Walsh CM, Karpatkin S. Risk for the acquired immunodeficiency syndrome among thrombocytopenic and nonthrombocytopenic homosexual men seropositive for the human immunodeficiency virus. Ann Intern Med 1987; 106: 383-386
• 13 Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, Rinaldo C, Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 61-66
• 14 Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann Intern Med 1986; 105: 234-237